The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

doi:10.1084/jem.184.3.1075

ELISpot, FluoroSpot and ELISA kits from Mabtech

This Article

	Full Text (PDF, 2826K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by O'Connell, J.
	Articles by Shanahan, F.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by O'Connell, J.
	Articles by Shanahan, F.


Social Bookmarking

	What's this?

ARTICLES

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

J O'Connell, GC O'Sullivan, JK Collins and F Shanahan
National University of Ireland, Cork, Ireland.

Tumors escape immunological rejection by a diversity of mechanisms. In this report, we demonstrate that the colon cancer cell SW620 expresses functional Fas ligand (FasL), the triggering agent of Fas receptor (FasR)-mediated apoptosis within the immune system. FasL mRNA and cell surface FasL were detected in SW620 cells using reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemical staining, respectively. We show that SW620 kills Jurkat T cells in a Fas-mediated manner. FasR-specific antisense oligonucleotide treatment, which transiently inhibited FasR expression, completely protected Jurkat cells from killing by SW620. FasL-specific antisense oligonucleotide treatment of SW620 inhibited its Jurkat-killing activity. FasL has recently been established as a mediator of immune privilege in mouse retina and testis. Our finding that colon cancer cells express functional FasL suggests it may play an analogous role in bestowing immune privilege on human tumors. HT29 and SW620 colon cancer cells were found to express FasR mRNA and cell surface FasR using RT-PCR and immunofluorescence flow cytometry, respectively. However, neither of these cells underwent apoptosis after treatment by the anti-FasR agonistic monoclonal antibody CH11. Our results therefore suggest a Fas counterattack model for immune escape in colon cancer, whereby the cancer cells resist Fas-mediated T cell cytotoxicity but express functional FasL, an apoptotic death signal to which activated T cells are inherently sensitive.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Mazar, J., Thomas, M., Bezrukov, L., Chanturia, A., Pekkurnaz, G., Yin, S., Kuznetsov, S. A., Robey, P. G., Zimmerberg, J. (2009). Cytotoxicity Mediated by the Fas Ligand (FasL)-activated Apoptotic Pathway in Stem Cells. J. Biol. Chem. 284: 22022-22028 [Abstract] [Full Text]
Di Carlo, E., D'Antuono, T., Pompa, P., Giuliani, R., Rosini, S., Stuppia, L., Musiani, P., Sorrentino, C. (2009). The Lack of Epithelial Interleukin-7 and BAFF/BLyS Gene Expression in Prostate Cancer as a Possible Mechanism of Tumor Escape from Immunosurveillance. Clin. Cancer Res. 15: 2979-2987 [Abstract] [Full Text]
Steinmann, C., Landsverk, M. L., Barral, J. M., Boehning, D. (2008). Requirement of Inositol 1,4,5-Trisphosphate Receptors for Tumor-mediated Lymphocyte Apoptosis. J. Biol. Chem. 283: 13506-13509 [Abstract] [Full Text]
Yang, M., Sun, T., Wang, L., Yu, D., Zhang, X., Miao, X., Liu, J., Zhao, D., Li, H., Tan, W., Lin, D. (2008). Functional Variants in Cell Death Pathway Genes and Risk of Pancreatic Cancer. Clin. Cancer Res. 14: 3230-3236 [Abstract] [Full Text]
Das, T., Sa, G., Paszkiewicz-Kozik, E., Hilston, C., Molto, L., Rayman, P., Kudo, D., Biswas, K., Bukowski, R. M., Finke, J. H., Tannenbaum, C. S. (2008). Renal Cell Carcinoma Tumors Induce T Cell Apoptosis through Receptor-Dependent and Receptor-Independent Pathways. J. Immunol. 180: 4687-4696 [Abstract] [Full Text]
Alvaro, T., Lejeune, M., Garcia, J. F., Salvado, Ma. T., Lopez, C., Bosch, R., Jaen, J., Escriva, P., Pons, L. E. (2008). Tumor-Infiltrated Immune Response Correlates with Alterations in the Apoptotic and Cell Cycle Pathways in Hodgkin and Reed-Sternberg Cells. Clin. Cancer Res. 14: 685-691 [Abstract] [Full Text]
Gregory, M. S., Saff, R. R., Marshak-Rothstein, A., Ksander, B. R. (2007). Control of Ocular Tumor Growth and Metastatic Spread by Soluble and Membrane Fas Ligand. Cancer Res. 67: 11951-11958 [Abstract] [Full Text]
Fluhr, H., Krenzer, S., Stein, G. M., Stork, B., Deperschmidt, M., Wallwiener, D., Wesselborg, S., Zygmunt, M., Licht, P. (2007). Interferon-{gamma} and tumor necrosis factor-{alpha} sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis. J. Cell Sci. 120: 4126-4133 [Abstract] [Full Text]
Su, C.-C., Lin, Y.-P., Cheng, Y.-J., Huang, J.-Y., Chuang, W.-J., Shan, Y.-S., Yang, B.-C. (2007). Phosphatidylinositol 3-Kinase/Akt Activation by Integrin-Tumor Matrix Interaction Suppresses Fas-Mediated Apoptosis in T Cells. J. Immunol. 179: 4589-4597 [Abstract] [Full Text]
Moretto, M. M., Weiss, L. M., Combe, C. L., Khan, I. A. (2007). IFN-{gamma}-Producing Dendritic Cells Are Important for Priming of Gut Intraepithelial Lymphocyte Response Against Intracellular Parasitic Infection. J. Immunol. 179: 2485-2492 [Abstract] [Full Text]
Fingleton, B., Carter, K. J., Matrisian, L. M. (2007). Loss of Functional Fas Ligand Enhances Intestinal Tumorigenesis in the Min Mouse Model. Cancer Res. 67: 4800-4806 [Abstract] [Full Text]
Raval, G., Biswas, S., Rayman, P., Biswas, K., Sa, G., Ghosh, S., Thornton, M., Hilston, C., Das, T., Bukowski, R., Finke, J., Tannenbaum, C. S. (2007). TNF-{alpha} Induction of GM2 Expression on Renal Cell Carcinomas Promotes T Cell Dysfunction. J. Immunol. 178: 6642-6652 [Abstract] [Full Text]
Zhang, B., Sun, T., Xue, L., Han, X., Zhang, B., Lu, N., Shi, Y., Tan, W., Zhou, Y., Zhao, D., Zhang, X., Guo, Y., Lin, D. (2007). Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis 28: 1067-1073 [Abstract] [Full Text]
Ryan, A. E., Shanahan, F., O'Connell, J., Houston, A. M. (2005). Addressing the "Fas Counterattack" Controversy: Blocking Fas Ligand Expression Suppresses Tumor Immune Evasion of Colon Cancer In vivo. Cancer Res. 65: 9817-9823 [Abstract] [Full Text]
Parmiani, G., Castelli, C., Rivoltini, L. (2005). Chemokine Receptor 7, A New Player in Regulating Apoptosis of CD8+ T Cells in Cancer Patients. Clin. Cancer Res. 11: 7587-7588 [Full Text]
Sun, T., Zhou, Y., Li, H., Han, X., Shi, Y., Wang, L., Miao, X., Tan, W., Zhao, D., Zhang, X., Guo, Y., Lin, D. (2005). FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. JEM 202: 967-974 [Abstract] [Full Text]
Guo, Z., Zhang, M., Tang, H., Cao, X. (2005). Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. Blood 106: 2033-2041 [Abstract] [Full Text]
Nadal, C., Maurel, J., Gallego, R., Castells, A., Longaron, R., Marmol, M., Sanz, S., Molina, R., Martin-Richard, M., Gascon, P. (2005). FAS/FAS Ligand Ratio: A Marker of Oxaliplatin-Based Intrinsic and Acquired Resistance in Advanced Colorectal Cancer. Clin. Cancer Res. 11: 4770-4774 [Abstract] [Full Text]
Chahlavi, A., Rayman, P., Richmond, A. L., Biswas, K., Zhang, R., Vogelbaum, M., Tannenbaum, C., Barnett, G., Finke, J. H. (2005). Glioblastomas Induce T-Lymphocyte Death by Two Distinct Pathways Involving Gangliosides and CD70. Cancer Res. 65: 5428-5438 [Abstract] [Full Text]
Dotti, G., Savoldo, B., Pule, M., Straathof, K. C., Biagi, E., Yvon, E., Vigouroux, S., Brenner, M. K., Rooney, C. M. (2005). Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. Blood 105: 4677-4684 [Abstract] [Full Text]
Zhang, X, Miao, X, Sun, T, Tan, W, Qu, S, Xiong, P, Zhou, Y, Lin, D (2005). Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J. Med. Genet. 42: 479-484 [Abstract] [Full Text]
Strater, J, Hinz, U, Hasel, C, Bhanot, U, Mechtersheimer, G, Lehnert, T, Moller, P (2005). Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease. Gut 54: 661-665 [Abstract] [Full Text]
Wolkersdorfer, G. W., Marx, C., Brown, J., Schroder, S., Fussel, M., Rieber, E. P., Kuhlisch, E., Ehninger, G., Bornstein, S. R. (2005). Prevalence of HLA-DRB1 Genotype and Altered Fas/Fas Ligand Expression in Adrenocortical Carcinoma. J. Clin. Endocrinol. Metab. 90: 1768-1774 [Abstract] [Full Text]
Bohana-Kashtan, O., Civin, C. I. (2005). Profiling Tumor Counterattack: Do Fas Ligand-Containing Microvesicles Reduce Anticancer Immunity?. Clin. Cancer Res. 11: 968-970 [Full Text]
Donskov, F., von der Maase, H., Marcussen, N., Hamilton-Dutoit, S., Madsen, H. H. T., Jensen, J. J., Hokland, M. (2004). Fas Ligand Expression in Metastatic Renal Cell Carcinoma During Interleukin-2 Based Immunotherapy: No In vivo Effect of Fas Ligand Tumor Counterattack. Clin. Cancer Res. 10: 7911-7916 [Abstract] [Full Text]
Hallermalm, K., De Geer, A., Kiessling, R., Levitsky, V., Levitskaya, J. (2004). Autocrine Secretion of Fas Ligand Shields Tumor Cells from Fas-Mediated Killing by Cytotoxic Lymphocytes. Cancer Res. 64: 6775-6782 [Abstract] [Full Text]
Yoo, Y.-G., Lee, M.-O. (2004). Hepatitis B Virus X Protein Induces Expression of Fas Ligand Gene through Enhancing Transcriptional Activity of Early Growth Response Factor. J. Biol. Chem. 279: 36242-36249 [Abstract] [Full Text]
Umemura, M., Kawabe, T., Shudo, K., Kidoya, H., Fukui, M., Asano, M., Iwakura, Y., Matsuzaki, G., Imamura, R., Suda, T. (2004). Involvement of IL-17 in Fas ligand-induced inflammation. Int Immunol 16: 1099-1108 [Abstract] [Full Text]
Asanuma, K., Tsuji, N., Endoh, T., Yagihashi, A., Watanabe, N. (2004). Survivin Enhances Fas Ligand Expression via Up-Regulation of Specificity Protein 1-Mediated Gene Transcription in Colon Cancer Cells. J. Immunol. 172: 3922-3929 [Abstract] [Full Text]
Murray, J. C., Symonds, P., Ward, W., Huggins, M., Tiga, A., Rice, K., Heng, Y. M., Todd, I., Robins, R. A. (2004). Colorectal Cancer Cells Induce Lymphocyte Apoptosis by an Endothelial Monocyte-Activating Polypeptide-II-Dependent Mechanism. J. Immunol. 172: 274-281 [Abstract] [Full Text]
Guo, Z., Zhang, M., An, H., Chen, W., Liu, S., Guo, J., Yu, Y., Cao, X. (2003). Fas ligation induces IL-1{beta}-dependent maturation and IL-1{beta}-independent survival of dendritic cells: different roles of ERK and NF-{kappa}B signaling pathways. Blood 102: 4441-4447 [Abstract] [Full Text]
Wu, X., McKenna, M. A., Feng, X., Nagy, T. R., McDonald, J. M. (2003). Osteoclast Apoptosis: The Role of Fas in Vivo and in Vitro. Endocrinology 144: 5545-5555 [Abstract] [Full Text]
Abrahams, V. M., Straszewski, S. L., Kamsteeg, M., Hanczaruk, B., Schwartz, P. E., Rutherford, T. J., Mor, G. (2003). Epithelial Ovarian Cancer Cells Secrete Functional Fas Ligand. Cancer Res. 63: 5573-5581 [Abstract] [Full Text]
Greil, R., Anether, G., Johrer, K., Tinhofer, I. (2003). Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools. J. Leukoc. Biol. 74: 311-330 [Abstract] [Full Text]
Chen, Y.-L., Chen, S.-H., Wang, J.-Y., Yang, B.-C. (2003). Fas Ligand on Tumor Cells Mediates Inactivation of Neutrophils. J. Immunol. 171: 1183-1191 [Abstract] [Full Text]
Tegeder, I., Grosch, S., Schmidtko, A., Haussler, A., Schmidt, H., Niederberger, E., Scholich, K., Geisslinger, G. (2003). G Protein-independent G1 Cell Cycle Block and Apoptosis with Morphine in Adenocarcinoma Cells: Involvement of p53 Phosphorylation. Cancer Res. 63: 1846-1852 [Abstract] [Full Text]
Kudo, D., Rayman, P., Horton, C., Cathcart, M. K., Bukowski, R. M., Thornton, M., Tannenbaum, C., Finke, J. H. (2003). Gangliosides Expressed by the Renal Cell Carcinoma Cell Line SK-RC-45 Are Involved in Tumor-induced Apoptosis of T Cells. Cancer Res. 63: 1676-1683 [Abstract] [Full Text]
Chopin, D., Barei-Moniri, R., Maille, P., Le Frere-Belda, M.-A., Muscatelli-Groux, B., Merendino, N., Lecerf, L., Stoppacciaro, A., Velotti, F. (2003). Human Urinary Bladder Transitional Cell Carcinomas Acquire the Functional Fas Ligand during Tumor Progression. Am. J. Pathol. 162: 1139-1149 [Abstract] [Full Text]
Xiao, S., Jodo, S., Sung, S.-s. J., Marshak-Rothstein, A., Ju, S.-T. (2002). A Novel Signaling Mechanism for Soluble CD95 Ligand. SYNERGY WITH ANTI-CD95 MONOCLONAL ANTIBODIES FOR APOPTOSIS AND NF-kappa B NUCLEAR TRANSLOCATION. J. Biol. Chem. 277: 50907-50913 [Abstract] [Full Text]
Embree-Ku, M., Boekelheide, K. (2002). FasL Deficiency Enhances the Development of Tumors in p53+/- Mice. Toxicol Pathol 30: 705-713 [Abstract]
Li, J. H., Kluger, M. S., Madge, L. A., Zheng, L., Bothwell, A. L. M., Pober, J. S. (2002). Interferon-{gamma} Augments CD95(APO-1/Fas) and Pro-Caspase-8 Expression and Sensitizes Human Vascular Endothelial Cells to CD95-Mediated Apoptosis. Am. J. Pathol. 161: 1485-1495 [Abstract] [Full Text]
Bugajska, U., Georgopoulos, N. T., Southgate, J., Johnson, P. W. M., Graber, P., Gordon, J., Selby, P. J., Trejdosiewicz, L. K. (2002). The Effects of Malignant Transformation on Susceptibility of Human Urothelial Cells to CD40-Mediated Apoptosis. JNCI J Natl Cancer Inst 94: 1381-1395 [Abstract] [Full Text]
Selam, B., Kayisli, U. A., Garcia-Velasco, J. A., Akbas, G. E., Arici, A. (2002). Regulation of Fas Ligand Expression by IL-8 in Human Endometrium. J. Clin. Endocrinol. Metab. 87: 3921-3927 [Abstract] [Full Text]
Chen, J. C., Lin, J.-H., Wu, L.-S., Tsai, Y.-F., Su, T. H., Chen, C. J., Chen, T. J. (2002). Luteotropic Roles of Prolactin in Early Pregnant Hamsters. Biol. Reprod. 67: 8-13 [Abstract] [Full Text]
Igney, F. H., Krammer, P. H. (2002). Immune escape of tumors: apoptosis resistance and tumor counterattack. J. Leukoc. Biol. 71: 907-920 [Abstract] [Full Text]
Buning, C., Kruger, K., Sieber, T., Schoeler, D., Schriever, F. (2002). Increased Expression of CD40 Ligand on Activated T Cells of Patients with Colon Cancer. Clin. Cancer Res. 8: 1147-1151 [Abstract] [Full Text]
Kurooka, M., Nuovo, G. J., Caligiuri, M. A., Nabel, G. J. (2002). Cellular Localization and Function of Fas Ligand (CD95L) in Tumors. Cancer Res. 62: 1261-1265 [Abstract] [Full Text]
Stewart, J. H. IV, Nguyen, D. M., Chen, G. A., Schrump, D. S., Rusch, S. V. (2002). Induction of apoptosis in malignant pleural mesothelioma cells by activation of the Fas (Apo-1/CD95) death-signal pathway. J. Thorac. Cardiovasc. Surg. 123: 295-302 [Abstract] [Full Text]
Jodo, S., Xiao, S., Hohlbaum, A., Strehlow, D., Marshak-Rothstein, A., Ju, S.-T. (2001). Apoptosis-inducing Membrane Vesicles. A NOVEL AGENT WITH UNIQUE PROPERTIES. J. Biol. Chem. 276: 39938-39944 [Abstract] [Full Text]
Riffkin, C. D., Gray, A. Z., Hawkins, C. J., Chow, C.W., Ashley, D. M. (2001). Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction. Neuro Oncol Duke 3: 229-240 [Abstract]
Selam, B., Kayisli, U. A., Mulayim, N., Arici, A. (2001). Regulation of Fas Ligand Expression by Estradiol and Progesterone in Human Endometrium. Biol. Reprod. 65: 979-985 [Abstract] [Full Text]
Ni, X., Hazarika, P., Zhang, C., Talpur, R., Duvic, M. (2001). Fas Ligand Expression by Neoplastic T Lymphocytes Mediates Elimination of CD8+ Cytotoxic T Lymphocytes in Mycosis Fungoides: A Potential Mechanism of Tumor Immune Escape?. Clin. Cancer Res. 7: 2682-2692 [Abstract] [Full Text]
Bennett, M W, O'Connell, J, Houston, A, Kelly, J, O'Sullivan, G C, Collins, J K, Shanahan, F (2001). Fas ligand upregulation is an early event in colonic carcinogenesis. J. Clin. Pathol. 54: 598-604 [Abstract] [Full Text]
Radoja, S., Saio, M., Frey, A. B. (2001). CD8+ Tumor-Infiltrating Lymphocytes Are Primed for Fas-Mediated Activation-Induced Cell Death But Are Not Apoptotic In Situ. J. Immunol. 166: 6074-6083 [Abstract] [Full Text]
Silvestris, F., Tucci, M., Cafforio, P., Dammacco, F. (2001). Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression. Blood 97: 1155-1164 [Abstract] [Full Text]
Wigginton, J. M., Park, J.-W., Gruys, M. E., Young, H. A., Jorcyk, C. L., Back, T. C., Brunda, M. J., Strieter, R. M., Ward, J., Green, J. E., Wiltrout, R. H. (2001). Complete Regression of Established Spontaneous Mammary Carcinoma and the Therapeutic Prevention of Genetically Programmed Neoplastic Transition by IL-12/Pulse IL-2: Induction of Local T Cell Infiltration, Fas/Fas Ligand Gene Expression, and Mammary Epithelial Apoptosis. J. Immunol. 166: 1156-1168 [Abstract] [Full Text]
Gastman, B. R., Yin, X.-M., Johnson, D. E., Wieckowski, E., Wang, G.-Q., Watkins, S. C., Rabinowich, H. (2000). Tumor-induced Apoptosis of T Cells: Amplification by a Mitochondrial Cascade. Cancer Res. 60: 6811-6817 [Abstract] [Full Text]
Ouhtit, A., Gorny, A., Muller, H. K., Hill, L. L., Owen-Schaub, L., Ananthaswamy, H. N. (2000). Loss of Fas-Ligand Expression in Mouse Keratinocytes during UV Carcinogenesis. Am. J. Pathol. 157: 1975-1981 [Abstract] [Full Text]
Beatty, G. L., Paterson, Y. (2000). IFN-{gamma} Can Promote Tumor Evasion of the Immune System In Vivo by Down-Regulating Cellular Levels of an Endogenous Tumor Antigen. J. Immunol. 165: 5502-5508 [Abstract] [Full Text]
Waku, T., Fujiwara, T., Shao, J., Itoshima, T., Murakami, T., Kataoka, M., Gomi, S., Roth, J. A., Tanaka, N. (2000). Contribution of CD95 Ligand-Induced Neutrophil Infiltration to the Bystander Effect in p53 Gene Therapy for Human Cancer. J. Immunol. 165: 5884-5890 [Abstract] [Full Text]
Reed, J. C. (2000). Mechanisms of Apoptosis. Am. J. Pathol. 157: 1415-1430 [Abstract] [Full Text]
Okada, K., Komuta, K., Hashimoto, S., Matsuzaki, S., Kanematsu, T., Koji, T. (2000). Frequency of Apoptosis of Tumor-infiltrating Lymphocytes Induced by Fas Counterattack in Human Colorectal Carcinoma and Its Correlation with Prognosis. Clin. Cancer Res. 6: 3560-3564 [Abstract] [Full Text]
Griffith, T. S., Anderson, R. D., Davidson, B. L., Williams, R. D., Ratliff, T. L. (2000). Adenoviral-Mediated Transfer of the TNF-Related Apoptosis-Inducing Ligand/Apo-2 Ligand Gene Induces Tumor Cell Apoptosis. J. Immunol. 165: 2886-2894 [Abstract] [Full Text]
Hopkins-Donaldson, S., Bodmer, J.-L., Bourloud, K. B., Brognara, C. B., Tschopp, J., Gross, N. (2000). Loss of Caspase-8 Expression in Highly Malignant Human Neuroblastoma Cells Correlates with Resistance to Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis. Cancer Res. 60: 4315-4319 [Abstract] [Full Text]
Costello, R. T., Mallet, F., Gaugler, B., Sainty, D., Arnoulet, C., Gastaut, J.-A., Olive, D. (2000). Human Acute Myeloid Leukemia CD34+/CD38- Progenitor Cells Have Decreased Sensitivity to Chemotherapy and Fas-induced Apoptosis, Reduced Immunogenicity, and Impaired Dendritic Cell Transformation Capacities. Cancer Res. 60: 4403-4411 [Abstract] [Full Text]
Wang, J., Fan, X., Lindholm, C., Bennett, M., O'Connoll, J., Shanahan, F., Brooks, E. G., Reyes, V. E., Ernst, P. B. (2000). Helicobacter pylori Modulates Lymphoepithelial Cell Interactions Leading to Epithelial Cell Damage through Fas/Fas Ligand Interactions. Infect. Immun. 68: 4303-4311 [Abstract] [Full Text]
Nakayama, H., Kitayama, J., Muto, T., Nagawa, H. (2000). Characterization of Intracellular Cytokine Profile of CD4(+) T Cells in Peripheral Blood and Tumor-draining Lymph Nodes of Patients with Gastrointestinal Cancer. Jpn J Clin Oncol 30: 301-305 [Abstract] [Full Text]
Bellone, G., Smirne, C., Carbone, A., Mareschi, K., Dughera, L., Farina, E. C., Alabiso, O., Valente, G., Emanuelli, G., Rodeck, U. (2000). Production and Pro-Apoptotic Activity of Soluble CD95 Ligand in Pancreatic Carcinoma. Clin. Cancer Res. 6: 2448-2455 [Abstract] [Full Text]
Favre-Felix, N., Fromentin, A., Hammann, A., Solary, E., Martin, F., Bonnotte, B. (2000). Cutting Edge: The Tumor Counterattack Hypothesis Revisited: Colon Cancer Cells Do Not Induce T Cell Apoptosis Via the Fas (CD95, APO-1) Pathway. J. Immunol. 164: 5023-5027 [Abstract] [Full Text]
TINHOFER, I, WYKYPIEL, H, MARSCHITZ, I, HENN, T, GREIL;, R, BENNETT, M W, O'CONNELL, J, ROCHE, D, BRADY, C, KELLY, J, COLLINS, J K, SHANAHAN, F, O'SULLIVAN, G C (2000). Gastric cancer cell lines lack Fas ligand (FasL) expression but kill T cells via a FasL independent pathway � Reply. Gut 46: 738-740 [Full Text]
Eerola, A.-K., Soini, Y., Paakko, P. (2000). A High Number of Tumor-infiltrating Lymphocytes Are Associated with a Small Tumor Size, Low Tumor Stage, and a Favorable Prognosis in Operated Small Cell Lung Carcinoma. Clin. Cancer Res. 6: 1875-1881 [Abstract] [Full Text]
Hohlbaum, A. M., Moe, S., Marshak-Rothstein, A. (2000). Opposing Effects of Transmembrane and Soluble FAS Ligand Expression on Inflammation and Tumor Cell Survival. JEM 191: 1209-1220 [Abstract] [Full Text]
Chow, W. A., Fang, J. J., Yee, J.-K. (2000). The IFN Regulatory Factor Family Participates in Regulation of Fas Ligand Gene Expression in T Cells. J. Immunol. 164: 3512-3518 [Abstract] [Full Text]
Brunner, T., Kasibhatla, S., Pinkoski, M. J., Frutschi, C., Yoo, N. J., Echeverri, F., Mahboubi, A., Green, D. R. (2000). Expression of Fas Ligand in Activated T Cells Is Regulated by c-Myc. J. Biol. Chem. 275: 9767-9772 [Abstract] [Full Text]
Gastman, B. R., Johnson, D. E., Whiteside, T. L., Rabinowich, H. (2000). Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events. Blood 95: 2015-2023 [Abstract] [Full Text]
Zeytun, A., Nagarkatti, M., Nagarkatti, P. S. (2000). Growth of FasL-bearing tumor cells in syngeneic murine host induces apoptosis and toxicity in Fas+ organs. Blood 95: 2111-2117 [Abstract] [Full Text]
Pinkoski, M. J., Brunner, T., Green, D. R., Lin, T. (2000). Fas and Fas ligand in gut and liver. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G354-G366 [Abstract] [Full Text]
Shinohara, H., Yagita, H., Ikawa, Y., Oyaizu, N. (2000). Fas Drives Cell Cycle Progression in Glioma Cells via Extracellular Signal-regulated Kinase Activation. Cancer Res. 60: 1766-1772 [Abstract] [Full Text]
Su, X., Hu, Q., Kristan, J. M., Costa, C., Shen, Y., Gero, D., Matis, L. A., Wang, Y. (2000). Significant Role for Fas in the Pathogenesis of Autoimmune Diabetes. J. Immunol. 164: 2523-2532 [Abstract] [Full Text]
Reimer, T., Herrnring, C., Koczan, D., Richter, D., Gerber, B., Kabelitz, D., Friese, K., Thiesen, H.-J. (2000). FasL:Fas Ratio-A Prognostic Factor in Breast Carcinomas. Cancer Res. 60: 822-828 [Abstract] [Full Text]
Liu, W, Kato, M, Akhand, A., Hayakawa, A, Suzuki, H, Miyata, T, Kurokawa, K, Hotta, Y, Ishikawa, N, Nakashima, I (2000). 4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J. Cell Sci. 113: 635-641 [Abstract]
Lee, J.-K., Sayers, T. J., Brooks, A. D., Back, T. C., Young, H. A., Komschlies, K. L., Wigginton, J. M., Wiltrout, R. H. (2000). IFN-{gamma}-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells. J. Immunol. 164: 231-239 [Abstract] [Full Text]
Velupillai, P., Yoshizawa, I., Dey, D. C., Nahill, S. R., Carroll, J. P., Bronson, R. T., Benjamin, T. L. (1999). Wild-Derived Inbred Mice Have a Novel Basis of Susceptibility to Polyomavirus-Induced Tumors. J. Virol. 73: 10079-10085 [Abstract] [Full Text]
Giovarelli, M., Musiani, P., Garotta, G., Ebner, R., Di Carlo, E., Kim, Y., Cappello, P., Rigamonti, L., Bernabei, P., Novelli, F., Modesti, A., Coletti, A., Ferrie, A. K., Lollini, P.-L., Ruben, S., Salcedo, T., Forni, G. (1999). A ""Stealth Effect"": Adenocarcinoma Cells Engineered to Express TRAIL Elude Tumor-Specific and Allogeneic T Cell Reactions. J. Immunol. 163: 4886-4893 [Abstract] [Full Text]
Ueno, T., Toi, M., Tominaga, T. (1999). Circulating Soluble Fas Concentration in Breast Cancer Patients. Clin. Cancer Res. 5: 3529-3533 [Abstract] [Full Text]
Buzyn, A., Petit, F., Ostankovitch, M., Figueiredo, S., Varet, B., Guillet, J.-G., Ameisen, J.-C., Estaquier, J. (1999). Membrane-Bound Fas (Apo-1/CD95) Ligand on Leukemic Cells: A Mechanism of Tumor Immune Escape in Leukemia Patients. Blood 94: 3135-3140 [Abstract] [Full Text]
Mitsiades, N., Poulaki, V., Leone, A., Tsokos, M. (1999). Fas-Mediated Apoptosis in Ewing's Sarcoma Cell Lines by Metalloproteinase Inhibitors. JNCI J Natl Cancer Inst 91: 1678-1684 [Abstract] [Full Text]
Gastman, B. R., Atarashi, Y., Reichert, T. E., Saito, T., Balkir, L., Rabinowich, H., Whiteside, T. L. (1999). Fas Ligand Is Expressed on Human Squamous Cell Carcinomas of the Head and Neck, and It Promotes Apoptosis of T Lymphocytes. Cancer Res. 59: 5356-5364 [Abstract] [Full Text]
Pierre, F., Perrin, P., Bassonga, E., Bornet, F., Meflah, K., Menanteau, J. (1999). T cell status influences colon tumor occurrence in Min mice fed short chain fructo-oligosaccharides as a diet supplement. Carcinogenesis 20: 1953-1956 [Abstract] [Full Text]
Bukowski, R. M., Rayman, P., Molto, L., Tannenbaum, C. S., Olencki, T., Peereboom, D., Tubbs, R., McLain, D., Budd, G. T., Griffin, T., Novick, A., Hamilton, T. A., Finke, J. (1999). Interferon-{{gamma}} and CXC Chemokine Induction by Interleukin 12 in Renal Cell Carcinoma. Clin. Cancer Res. 5: 2780-2789 [Abstract] [Full Text]
Reed, J. C. (1999). Dysregulation of Apoptosis in Cancer. JCO 17: 2941-2941 [Abstract] [Full Text]
Holmstrom, T. H., Tran, S. E. F., Johnson, V. L., Ahn, N. G., Chow, S. C., Eriksson, J. E. (1999). Inhibition of Mitogen-Activated Kinase Signaling Sensitizes HeLa Cells to Fas Receptor-Mediated Apoptosis. Mol. Cell. Biol. 19: 5991-6002 [Abstract] [Full Text]
Shibakita, M., Tachibana, M., Dhar, D. K., Kotoh, T., Kinugasa, S., Kubota, H., Masunaga, R., Nagasue, N. (1999). Prognostic Significance of Fas and Fas Ligand Expressions in Human Esophageal Cancer. Clin. Cancer Res. 5: 2464-2469 [Abstract] [Full Text]
Mitsiades, N., Poulaki, V., Mastorakos, G., Tseleni-Balafouta, S., Kotoula, V., Koutras, D. A., Tsokos, M. (1999). Fas Ligand Expression in Thyroid Carcinomas: A Potential Mechanism of Immune Evasion. J. Clin. Endocrinol. Metab. 84: 2924-2932 [Abstract] [Full Text]
Srivastava, R. K., Sasaki, C. Y., Hardwick, J. M., Longo, D. L. (1999). Bcl-2-Mediated Drug Resistance: Inhibition of Apoptosis by Blocking Nuclear Factor of Activated T Lymphocytes (Nfat)-Induced FAS Ligand Transcription. JEM 190: 253-266 [Abstract] [Full Text]
O'Connell, J., Bennett, M. W., O'Sullivan, G. C., O'Callaghan, J., Collins, J. K., Shanahan, F. (1999). Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege. CVI 6: 457-463 [Abstract] [Full Text]
MOALEM, G., MONSONEGO, A., SHANI, Y., COHEN, I. R., SCHWARTZ, M. (1999). Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J. 13: 1207-1217 [Abstract] [Full Text]
Matsui, S., Ahlers, J. D., Vortmeyer, A. O., Terabe, M., Tsukui, T., Carbone, D. P., Liotta, L. A., Berzofsky, J. A. (1999). A Model for CD8+ CTL Tumor Immunosurveillance and Regulation of Tumor Escape by CD4 T Cells Through an Effect on Quality of CTL. J. Immunol. 163: 184-193 [Abstract] [Full Text]
Shimizu, M., Fontana, A., Takeda, Y., Yagita, H., Yoshimoto, T., Matsuzawa, A. (1999). Induction of Antitumor Immunity with Fas/APO-1 Ligand (CD95L)-Transfected Neuroblastoma Neuro-2a Cells. J. Immunol. 162: 7350-7357 [Abstract] [Full Text]